IGC Pharma, Inc.IGCNYSE
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank64
3Y CAGR-47.6%
5Y CAGR+29.3%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-47.6%/yr
vs +102.3%/yr prior
5Y CAGR
+29.3%/yr
Recent deceleration
Acceleration
-149.9pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
3.6x
Strong expansion
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 17.16 | -17.6% |
| 2024 | 20.82 | +6.3% |
| 2023 | 19.59 | -83.6% |
| 2022 | 119.49 | +42.9% |
| 2021 | 83.65 | +1660.2% |
| 2020 | 4.75 | -66.0% |
| 2019 | 13.97 | +95.9% |
| 2018 | 7.13 | -65.7% |
| 2017 | 20.78 | +1452.6% |
| 2016 | 1.34 | - |